Anum Syyam

Ms. Anum Syyam

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2022 in BioTechniques
Verified
Journal Article
Open access
ASAnum Syyam
Anum Syyam
ANAmjad Nawaz
Amjad Nawaz
AIAroosa Ijaz
Aroosa Ijaz
USUmar Sajjad
Umar Sajjad
AFAnila Fazil
Anila Fazil
SASamia Afzal
Samia Afzal
Since the isolation of adenovirus (AdV) in 1953, AdVs have been used as vectors for various therapeutic purposes, such as gene therapy in cancers and other malignancies, vaccine development and del... TWEETABLE ABSTRACT Adenovirus vectors have been used for vaccine development, gene therapy and delivery of the CRISPR-Cas9 system. Several modifications have been introduced to enhance the efficacy...

20 February 2023 in Livers
Verified
Journal Article
Open access
PDF file
ASAnum Syyam
Anum Syyam
HAHira Raheem Akbar
Hira Raheem Akbar
ZJZuzana Macek Jilkova
Zuzana Macek Jilkova
SASamia Afzal
Samia Afzal
Globally, hepatocellular carcinoma (HCC) is a significant cause of mortality and morbidity among chronically infected HCV patients. It is established that HCV is a primary risk factor for HCC progression. The treatment of HCV infection has been transformed by the introduction of DAAs with high rates of virological clearance. The reduction in cirrhosis-related consequences, particularly HCC, is the long-term objective of DAAs therapy for HCV. Although the risk of developing HCC is decreased in HCV patients who achieve a disease-sustaining virological response, these patients are nevertheless at risk, especially those with severe fibrosis and cirrhosis. Previous studies have shown that HCV induce several mechanisms of hepatocarcinogenesis in the host’s hepatic micro- and macro-environment, which leads to HCC progression. In an HCV-altered environment, compensatory liver regeneration favors chromosomal instability and irreversible alterations, which encourage hepatocyte neoplastic transformation and the development of malignant clones. These mechanisms involve a series of genetic and epigenetic modifications including host genetic factors, dysregulation of several signaling pathways, histone, and DNA modifications including methylation and acetylation. This review highlights the genetic and epigenetic factors that lead to the development of HCC in chronic HCV-infected individuals and can be targeted for earlier HCC diagnosis and prevention.